Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model
Bhuvanesh Dave(University Hospital Galway), Jenny C. Chang(Universität Hamburg), Michael T. Lewis(Baylor College of Medicine), Thomas F. Westbrook(Baylor College of Medicine), Lacey E. Dobrolecki(Baylor College of Medicine), Meng-Fen Wu(Baylor College of Medicine), David J. Tweardy(The University of Texas MD Anderson Cancer Center), Susan G. Hilsenbeck(Baylor College of Medicine), Xiaomei Zhang(The University of Texas MD Anderson Cancer Center), Melissa D. Landis(Baylor College of Medicine), Dan Liu(Shaoyang University)
Cited by 62
Related Papers
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
|Cell|2009|1k
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
|Nature|2017|853
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
|Cancer Cell|2017|656